« Ajit Singh, Formerly of BioImagene, Joins Venture Capital Firm Artiman Ventures | Main | Online Film Criticism Flourishing According to Roger Ebert »

Comments

Theo

Isn't this similar to IVD manufacturers and pharma companies setting up or acquiring a CLIA lab? i.e., Novartis/Genoptix or Celera/Berkeley? A CLIA lab enables vertical integration. In the case of a CRO, the identical assay that is used throughout the trial can now be assured of availability post launch. For a pharma company with a drug/diagnostic combination - getting ready to launch without that particular assay having wide, or any availability - is a stumbling block to success.

The comments to this entry are closed.

Corporate Underwriters





  •  

     
     
     
     
     

Search Lab Soft News

  • Google

    WWW
    labsoftnews.typepad.com

Subscribe to Lab Soft News (Email and RSS Feeds)

Your email address:


Powered by FeedBlitz

September 2017

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
Blog powered by Typepad
Member since 12/2005